Januvia, Byetta
The FDA has issued several warnings about links between Byetta and Januvia to complications related to pancreatic diseases. Continue reading →
View ArticleType 2 diabetes drugs may increase risk of pancreatic cancer
A commonly prescribed class of Type 2 diabetes drugs known as incretin mimetics may put users at risk for developing pancreatic cancer, according to new research published in the British Medical...
View ArticleFDA Orders Stronger Black Box Warning on Avandia
Diabetic patients consuming GlaxoSmithKline's Avandia to keep sugar levels at bay may now have to shift to some substitute drug as the US health agency has confirmed that the popular diabetes medicine...
View ArticleJanuvia and Byetta may increase chances of developing pancreatic cancer
David Dearing discusses the dangers of type 2 diabetes drugs, such as Januvia and Byetta which have been linked to pancreatic cancer The post Januvia and Byetta may increase chances of developing...
View ArticleJanuvia Lawsuits on the Rise
Four popular diabetes drugs are rapidly gaining critical notoriety in the United States. Januvia (Merck), Janumet (Merck), Byetta (Amylin / Bristol-Myers Squibb) and Victoza (Norvo Nordisk) have been...
View ArticleThe Incretin Mimetic Therapy Litigation
Byetta, Januvia, Janumet and Victoza are fairly new drugs designed to help regulate blood sugar levels in people with Type 2 Diabetes. They are in a class of drugs known as incretin mimetics, and they...
View ArticleMass Torts Update
Lawyers in our firm’s Mass Torts Section have been working on a number of significant projects. I will give a brief summary on several of them. Andy Birchfield heads up this Section for the firm, and...
View ArticleAn Update On Activity In Our Firms Mass Torts Section
Some of the drugs and devices we are currently working on: Talcum Powder, Transvaginal Mesh, Xarelto, 3M Bair Hugger, Byetta, Januvia, Essure, GranuFlo, Low-T, Invokana, IVC Filter, Lipitor, Hip...
View Article
